PHOTO
Dubai, UAE: Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced it will host its annual EMEA Invisalign Scientific Symposium on July 2nd and 3rd digitally, providing an opportunity for orthodontists to delve into the science behind the Invisalign system, as well as glean the latest advanced clinical knowledge from luminaries of orthodontic pedagogy.
The 2021 Invisalign Scientific Symposium agenda explores three key themes:
- A review of the efficacy and efficiency of Invisalign aligners vs fixed appliances, especially in relation to predictability, effectiveness, and treatment stability.
- The role of orthodontics in oral and mental health for growing patients, focusing on patient satisfaction and quality of life, pain perception and anxiety, and the impact of orthodontic appliances on oral hygiene.
- The possibilities offered by clear aligner therapy, including maxillary expansion, Class III occlusions, inter-disciplinary approaches, and auxiliary techniques.
Keynote lectures will be delivered by global clinical speakers, including Prof. Juan Carlos Rivero Lesmes from Spain who will be presenting about the ‘Efficiency with biomechanics and clear aligners’, whilst patients’ quality of life is the focus of the lecture by Dr. Meiya Gao from China, explaining the ‘Comparison of pain perception, anxiety, and impacts on oral health-related quality of life between patients receiving clear aligners and fixed appliances during the initial stage of orthodontic treatment’.
The renowned American ‘Orthocoach`, Dr. Regina Blevins will be discussing ‘Oral hygiene amongst growing patients - fixed braces vs the Invisalign system’. She is joined on the programme by Prof. Luca Levrini from Italy whose main area of study is the treatment of younger patients. Prof. Levrini will be exploring ‘Maxillary expansion with Invisalign First treatment in the mixed dentition, pre and post treatment predictability’.
Dr. Tommaso Castroflorio (Italy) will be one of key speakers at the upcoming Symposium. His talk focuses on aligner deformation and looks at whether orthodontic movement is just a question of attachments and whether aligner deformation in Class II and open bite treatments can be predicted.
Previewing his lecture, he advised that he will be introducing his peers to some features of the latest Invisalign G8 innovations to address aligner deformation, as he explained: “We - as orthodontists - know that when we apply the aligner on teeth, it springs back to its original position and original shape – then, the force is delivered to the teeth producing the orthodontic movement. The greater the deformation, the larger the activation force produced by the aligners. This is the reason why we need to work with a material like Invisalign SmartForce.”
Dr. Michael Davidson, Director of Clinical and Professional Education EMEA for Align
Technology commented. “Building on the success of the first edition in 2020, Align Technology EMEA is looking forward to welcoming attendees and presenters to the second virtual edition of the EMEA Invisalign Scientific Symposium. From the outset, the event scientific team has endeavoured to showcase the best in global research and clinical content which is both robust, and relevant to the orthodontic practitioner. Over the two days, attendees can expect presenters to discuss topics such as: how predictability and efficiency are impacted by latest innovations that form part of the Align digital orthodontic workflow. Delegates can also be assured that sessions will relate to a range of clinical case types, with the ultimate goal of oral and general health improvement for patients. To wrap things up, and as an event first, Align has partnered with European Academy of Paediatric Dentistry to bring a scientific poster presentation session which is focused on the growing patient. We look forward to welcoming all doctors to this truly world class event.”
The lectures will be delivered in English, with simultaneous translations available in Italian, German, French, Spanish, Russian, and Turkish. Access to the full two-day programme will cost EUR 200 for Invisalign providers and EUR 250 for non-Invisalign providers. For more information, including the full programme agenda and registration visit:
https://www.yourbrillianceenhanced.com/invisalignscientificsymposium2021
Media access
For media access, please sign up to the Invisalign Scientific Symposium using this form (please use your corporate email): https://forms.gle/tFJfU4CF7bbXYqy77 - Scientific Symposium
About Align Technology, Inc.
Align Technology designs, manufactures and offers the Invisalign system, the most advanced clear aligner system in the world, iTero intraoral scanners and services, and exocad CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 200 thousand doctor customers and is key to accessing Align’s 500 million consumer market opportunity worldwide. Align has helped doctors treat over 10.2 million patients with the Invisalign system and is driving the evolution in digital dentistry through the Align Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.
For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero intraoral scanners, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.
For more information, please contact:
Natalie Flavin | Definition PR | natalie@definitionagency.com
Fatima Khawer | Definition PR | fatima@definitionagency.com
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
